These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8094705)

  • 1. Progress in the treatment of tardive dyskinesia: theory and practice.
    Feltner DE; Hertzman M
    Hosp Community Psychiatry; 1993 Jan; 44(1):25-34. PubMed ID: 8094705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Essali A; Deirawan H; Soares-Weiser K; Adams CE
    Cochrane Database Syst Rev; 2011 Nov; (11):CD000206. PubMed ID: 22071797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clozapine on preexisting tardive dyskinesia.
    Littrell K; Magill AM
    J Psychosoc Nurs Ment Health Serv; 1993 Sep; 31(9):14-8. PubMed ID: 7901407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of tardive dyskinesia with ceruletide: a double-blind, placebo-controlled study.
    Kojima T; Yamauchi T; Miyasaka M; Koshino Y; Nakane Y; Takahashi R; Shimazono Y; Yagi G
    Psychiatry Res; 1992 Aug; 43(2):129-36. PubMed ID: 1357701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia as a risk factor for negative symptoms.
    Wright P; Taylor M
    Br J Psychiatry; 1994 May; 164(5):700-1; author reply 702. PubMed ID: 7921731
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Schizophr Res; 1991; 4(2):109-20. PubMed ID: 1674881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine in the treatment of tardive dyskinesia.
    Duncan E; Adler L; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1990 Dec; 10(6):414-6. PubMed ID: 1981070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia as a risk factor for negative symptoms.
    Taylor SJ
    Br J Psychiatry; 1994 May; 164(5):701-2. PubMed ID: 7921732
    [No Abstract]   [Full Text] [Related]  

  • 19. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is tardive dyskinesia a unique disorder?
    Marsden CD
    Psychopharmacology Suppl; 1985; 2():64-71. PubMed ID: 2860661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.